JW Lifescience Corporation (KRX:234080)

JW Lifescience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	194,796	168,472	199,286	188,137	214,461	328,567
Market Cap Growth	14.78%	-15.46%	5.93%	-12.27%	-34.73%	4.80%
Enterprise Value	217,850	157,490	227,270	221,603	261,011	360,376
Last Close Price	12580.00	10880.00	12304.53	11176.16	12240.30	17697.16
PE Ratio	4.09	3.83	7.08	12.58	16.61	18.99
Forward PE	-	9.92	9.92	9.92	9.92	13.92
PS Ratio	0.78	0.76	0.96	1.00	1.26	1.79
PB Ratio	0.91	0.84	1.25	1.34	1.63	2.48
P/TBV Ratio	1.41	1.37	1.28	1.38	1.69	2.57
P/FCF Ratio	7.08	4.17	6.77	31.10	19.17	10.66
P/OCF Ratio	4.74	3.32	5.30	13.32	7.11	7.03
EV/Sales Ratio	0.88	0.71	1.10	1.17	1.54	1.96
EV/EBITDA Ratio	3.37	3.05	4.90	5.27	6.27	6.97
EV/EBIT Ratio	4.60	4.39	7.36	8.18	9.19	9.14
EV/FCF Ratio	7.91	3.90	7.73	36.63	23.33	11.69
Debt / Equity Ratio	0.23	0.35	0.29	0.48	0.35	0.28
Debt / EBITDA Ratio	0.93	1.34	1.00	1.60	1.12	0.71
Debt / FCF Ratio	1.77	1.72	1.57	11.11	4.16	1.19
Asset Turnover	0.87	0.77	0.81	0.80	0.78	0.88
Inventory Turnover	6.42	5.61	6.80	6.54	6.38	7.63
Quick Ratio	0.79	0.87	0.89	1.03	0.45	0.54
Current Ratio	1.21	1.32	1.14	1.31	0.77	0.82
Return on Equity (ROE)	24.72%	24.45%	18.78%	11.01%	9.78%	13.56%
Return on Assets (ROA)	7.70%	7.71%	7.58%	7.17%	8.19%	11.86%
Return on Capital (ROIC)	9.21%	9.43%	9.34%	8.78%	10.24%	14.66%
Return on Capital Employed (ROCE)	15.50%	14.60%	19.10%	15.70%	21.00%	27.20%
Earnings Yield	24.43%	26.11%	14.12%	7.95%	6.02%	5.27%
FCF Yield	14.13%	23.97%	14.76%	3.21%	5.22%	9.38%
Dividend Yield	3.94%	4.60%	4.06%	4.47%	4.08%	2.83%
Payout Ratio	16.27%	17.60%	27.51%	51.75%	61.31%	45.76%
Buyback Yield / Dilution	-	-	-	0.61%	1.61%	-
Total Shareholder Return	3.97%	4.60%	4.06%	5.09%	5.69%	2.83%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.